Related Experiment Video
Updated: Feb 2, 2026

A Procedure to Study the Effect of Prolonged Food Restriction on Heroin Seeking in Abstinent Rats
Published on: November 11, 2013
Could prenatal food insecurity influence neonatal abstinence syndrome severity?
Ruth Rose-Jacobs1, Michelle Trevino-Talbot2, Christine Lloyd-Travaglini3
1Pediatrics, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA.
Insights
Prenatal food insecurity in pregnant women receiving opioid treatment is linked to a higher risk of their infants needing medication for neonatal abstinence syndrome (NAS). This highlights a critical connection between maternal nutrition and infant health outcomes.
Area of Science:
- Obstetrics and Gynecology
- Neonatal Health
- Public Health Nutrition
Background:
- Prenatal food insecurity is a known risk factor for adverse maternal and infant health outcomes.
- Opioid use disorder during pregnancy, often treated with opioid agonist therapy, presents unique challenges for maternal and infant well-being.
- Neonatal Abstinence Syndrome (NAS) is a significant concern for infants exposed to opioids in utero.
Purpose of the Study:
- To investigate the association between prenatal food insecurity and the severity of neonatal abstinence syndrome (NAS) in infants born to mothers receiving opioid agonist treatment.
- To determine if maternal food insecurity predicts the need for pharmacological treatment for NAS.
- To explore the relationship between prenatal food insecurity and the length of hospital stay for NAS management.
Main Methods:
- A prospective cohort study was conducted at a large urban safety-net hospital.
- Participants included 75 pregnant women receiving opioid agonist treatment (methadone or buprenorphine) during their third trimester.
- Food insecurity was assessed using a validated screener, and NAS severity was measured by the extent of pharmacological treatment and length of hospital stay, with data abstracted from medical records.
Main Results:
- A significant proportion of infants (81%) required pharmacological treatment for NAS, with a mean hospital length of stay of 19.9 days.
- Maternal food insecurity was associated with an increased risk of infant NAS pharmacological treatment, even after adjusting for maternal depression and methadone treatment.
- The association between food insecurity and the length of hospital stay for NAS was inconclusive.
Conclusions:
- Prenatal food insecurity appears to be a significant risk factor associated with an increased likelihood of infants requiring pharmacological treatment for neonatal abstinence syndrome among women undergoing opioid agonist treatment.
- These findings underscore the importance of addressing food insecurity in pregnant women with opioid use disorder to potentially mitigate NAS severity.
- Further research is warranted to explore the mechanisms linking food insecurity to NAS severity and to develop targeted interventions.
Background And Aims:
In general populations, prenatal food insecurity negatively affects maternal and infant health. Our aim was to estimate and test the association between prenatal food insecurity and neonatal abstinence syndrome (NAS) severity.
Design/Setting:
Single-site prospective cohort design. Women receiving opioid agonist treatment with methadone or buprenorphine were interviewed (including demographics and food insecurity) during the third trimester at the combined obstetric/opioid use disorder treatment clinic at Boston Medical Center (BMC) in Boston, MA, USA, a large urban safety-net hospital. During postnatal hospitalization, infants were assessed and treated per hospital NAS protocol. Maternal clinic and infant hospitalization data were abstracted from medical records.
Participants:
Women (n = 75; aged ≥ 18 years; fluent English; singleton pregnancy; intending to deliver at BMC and maintain parental custody) receiving care in the specialized clinic were study eligible (2013-15). Women who delivered infants < 36 weeks gestational age or required prolonged newborn intensive care unit stay were excluded from analyses.
Primary Measurements:
Predictors: validated two-question Hunger Vital Sign™ food insecurity screener; outcomes: extent of NAS pharmacological treatment and length of hospital stay (LOS) for NAS.
Findings:
Of the mother-infant dyads, 61 (81%) infants were treated pharmacologically for NAS. Mean hospital LOS was 19.9 (standard deviation = 9.4) days. Maternal food insecurity (n = 43, 57.3%) was associated with infant NAS pharmacological treatment in logistic regression analyses individually adjusted for prenatal: maternal depression [adjusted odds ratios (aOR) = 3.69 (95% confidence intervals (CI) = 1.02-13.43, P = 0.05)] and methadone agonist treatment [aOR = 4.17 (95% CI = 1.05-16.50, P = 0.04)]. Associations of food insecurity and LOS were inconclusive regardless of covariate control (P > 0.05).
Conclusion:
Among women receiving opioid agonist treatment, prenatal food insecurity appears to be associated with increased risk for neonatal abstinence syndrome pharmacological treatment.
Related Concept Videos
Regulation of Food Intake
Microorganisms in Agriculture and Food industry
The Influence of Affect on Cognition
The Influence of Cognition on Affect
Bioavailability: Influencing Factors
Nephrotic Syndrome I : Introduction

